Capital Cell is a pioneering European equity crowdfunding platform specializing in biotech and life sciences. It connects individual and institutional investors with promising biotech startups, allowing them to invest in companies developing innovative healthcare solutions. The platform focuses on projects with high growth potential, aiming to contribute to significant advancements in medical science while offering investors the opportunity to participate in potentially high-return ventures
Licence/regulation: CAPITAL CELL licensed under European Crowdfunding Service Providers (ECSP) regulation
Capital Cell operates as an Equity crowdfunding platform offering investors to invest in startups and early-stage companies through acquiring company shares. On the other hand offering companies am alternative fundraising tool to raise funds from a large pool of investors.
On Capital Cell you can invest in European startups from healthcare and biotech industries
When investing on Capital Cell you invest in early-stage companies which makes it a high-risk investment since statistically 9 of 10 early-stage companies fail. You as an investor have to carefully evaluate such investments including product, product-market fit, company team and their ability to successfully develop a company, total addressable and reachable market and company growth potential, and other risks depending on business specifics.
This platform have no rating yet. Be the first to rate!